|
Volumn 38, Issue 990, 1996, Pages 111-112
|
Zafirlukast for asthma
[No Author Info available]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ASTEMIZOLE;
BECLOMETASONE DIPROPIONATE;
BETA ADRENERGIC RECEPTOR STIMULATING AGENT;
CALCIUM ANTAGONIST;
CARBAMAZEPINE;
CISAPRIDE;
CORTICOSTEROID;
CROMOGLYCATE DISODIUM;
CYCLOSPORIN;
CYCLOSPORIN A;
DIHYDROPYRIDINE DERIVATIVE;
ERYTHROMYCIN;
FLUNISOLIDE;
FLUTICASONE PROPIONATE;
LEUKOTRIENE RECEPTOR BLOCKING AGENT;
NEDOCROMIL SODIUM;
PHENYTOIN;
SALMETEROL;
SALMETEROL XINAFOATE;
TERFENADINE;
THEOPHYLLINE;
TOLBUTAMIDE;
TRIAMCINOLONE ACETONIDE;
WARFARIN;
ZAFIRLUKAST;
ARTICLE;
ASTHMA;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG BIOAVAILABILITY;
DRUG COST;
DRUG FORMULATION;
DRUG INDICATION;
DRUG INFORMATION;
DRUG MECHANISM;
DRUG METABOLISM;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL SYMPTOM;
HEADACHE;
HUMAN;
INHALATIONAL DRUG ADMINISTRATION;
MAINTENANCE THERAPY;
METERED DOSE INHALER;
NONHUMAN;
ORAL DRUG ADMINISTRATION;
SUSTAINED RELEASE PREPARATION;
TABLET;
ANTI-ASTHMATIC AGENTS;
ASTHMA;
CHRONIC DISEASE;
CLINICAL TRIALS;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
HUMANS;
LEUKOTRIENE ANTAGONISTS;
TOSYL COMPOUNDS;
WARFARIN;
|
EID: 0030463791
PISSN: 0025732X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (11)
|
References (0)
|